{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:28:52Z","timestamp":1770719332789,"version":"3.49.0"},"reference-count":20,"publisher":"Rockefeller University Press","issue":"2","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1997,1,20]]},"abstract":"<jats:p>Recombinant HLA-A2, HLA-B8, or HLA-B53 heavy chain produced in Escherichia coli was combined with recombinant \u03b22-microglobulin (\u03b22m) and a pool of randomly synthesised nonamer peptides. This mixture was allowed to refold to form stable major histocompatability complex (MHC) class I complexes, which were then purified by gel filtration chromatography. The peptides bound to the MHC class I molecules were subsequently eluted and sequenced as a pool. Peptide binding motifs for these three MHC class I molecules were derived and compared with previously described motifs derived from analysis of naturally processed peptides eluted from the surface of cells. This comparison indicated that the peptides bound by the recombinant MHC class I molecules showed a similar motif to naturally processed and presented peptides, with the exception of the peptide COOH terminus. Whereas the motifs derived from naturally processed peptides eluted from HLA-A2 and HLA-B8 indicated a strong preference for hydrophobic amino acids at the COOH terminus, this preference was not observed in our studies. We propose that this difference reflects the effects of processing or transport on the peptide repertoire available for binding to MHC class I molecules in vivo.<\/jats:p>","DOI":"10.1084\/jem.185.2.367","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:49:30Z","timestamp":1027702170000},"page":"367-372","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":35,"title":["HLA Class I Binding Motifs Derived from Random Peptide Libraries Differ at the COOH Terminus from Those of Eluted Peptides"],"prefix":"10.1084","volume":"185","author":[{"given":"Miles P.","family":"Davenport","sequence":"first","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine J.","family":"Smith","sequence":"additional","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Barouch","sequence":"additional","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Reid","sequence":"additional","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda M.","family":"Bodnar","sequence":"additional","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Willis","sequence":"additional","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald F.","family":"Hunt","sequence":"additional","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[{"name":"From the *Molecular Immunology Group, Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, OX3 9DU, United Kingdom; \u2021Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and the \u00a7Department of Chemistry, University of Virginia, Charlottesville, Virginia 22903"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"291","published-online":{"date-parts":[[1997,1,20]]},"reference":[{"key":"2023072507045868000_B1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/329506a0","article-title":"Structure of human class I histocompatibility antigen, HLA-A2","volume":"329","author":"Bjorkman","year":"1987","journal-title":"Nature (Lond)"},{"key":"2023072507045868000_B2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/351290a0","article-title":"Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature (Lond)"},{"key":"2023072507045868000_B3"},{"key":"2023072507045868000_B4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/353726a0","article-title":"Peptide binding specificity of the molecular chaperone BiP","volume":"353","author":"Flynn","year":"1991","journal-title":"Nature (Lond)"},{"key":"2023072507045868000_B5"},{"key":"2023072507045868000_B6","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1073\/pnas.89.8.3429","article-title":"HLA-A2 peptide complexes: Refolding and crystalisation of molecules expressed in Escherichia coliand complexed with single antigenic peptides","volume":"89","author":"Garboczi","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507045868000_B7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/360434a0","article-title":"Molecular analysis of the association of HLA-B53 and resistance to severe malaria","volume":"360","author":"Hill","year":"1992","journal-title":"Nature (Lond)"},{"key":"2023072507045868000_B8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to class I MHC molecule HLA-A2.1 by mass spectrometry","volume":"255","author":"Hunt","year":"1992","journal-title":"Science (Wash DC)"},{"key":"2023072507045868000_B9","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.4049\/jimmunol.149.11.3580","article-title":"Sequence motifs important for peptide binding to the human class I molecule, HLA-A2","volume":"149","author":"Parker","year":"1992","journal-title":"J Immunol"},{"key":"2023072507045868000_B10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/367648a0","article-title":"Selectivity of MHCencoded peptide transporters from human, mouse and rat","volume":"367","author":"Momburg","year":"1994","journal-title":"Nature (Lond)"},{"key":"2023072507045868000_B11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.1546329","article-title":"HLAA2.1 associated peptides from a mutant cell line: a second pathway of antigen presentation","volume":"255","author":"Henderson","year":"1992","journal-title":"Science (Wash DC)"},{"key":"2023072507045868000_B12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/365262a0","article-title":"MHC-linked LMPgene products specifically alter peptidase activities of the proteasome","volume":"365","author":"Driscoll","year":"1993","journal-title":"Nature (Lond)"},{"key":"2023072507045868000_B13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/365264a0","article-title":"\u03b3-interferon and expression of MHC genes regulates peptide hydrolysis by proteasomes","volume":"365","author":"Gaczynska","year":"1993","journal-title":"Nature (Lond)"},{"key":"2023072507045868000_B14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/eji.1830250444","article-title":"Analysis of the fine specificity of rat, mouse, and human TAP peptide transporters","volume":"25","author":"Neefjes","year":"1995","journal-title":"Eur J Immunol"},{"key":"2023072507045868000_B15","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.4049\/jimmunol.152.8.3913","article-title":"Definition of specific peptide motifs for four major HLA-A alleles","volume":"152","author":"Kubo","year":"1994","journal-title":"J Immunol"},{"key":"2023072507045868000_B16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/eji.1830230222","article-title":"A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA-B8 revealed by analysis of epitopes and eluted peptides","volume":"23","author":"Sutton","year":"1993","journal-title":"Eur J Immunol"},{"key":"2023072507045868000_B17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/intimm\/5.10.1229","article-title":"Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis","volume":"5","author":"Malcherek","year":"1993","journal-title":"Int Immunol"},{"key":"2023072507045868000_B18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4049\/jimmunol.152.2.620","article-title":"Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8","volume":"152","author":"DiBrino","year":"1994","journal-title":"J Immunol"},{"key":"2023072507045868000_B19","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.4049\/jimmunol.151.6.3361","article-title":"Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC restricted peptide epitope","volume":"151","author":"Gotch","year":"1993","journal-title":"J Immunol"},{"key":"2023072507045868000_B20","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1172\/JCI118287","article-title":"HLA class I\u2013restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterisation of patterns of cytokine release","volume":"96","author":"Koziel","year":"1995","journal-title":"J Clin Invest"}],"container-title":["The Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/185\/2\/367\/1680243\/5375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/185\/2\/367\/1680243\/5375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T07:37:22Z","timestamp":1690270642000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/185\/2\/367\/7082\/HLA-Class-I-Binding-Motifs-Derived-from-Random"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1,20]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,1,20]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.185.2.367","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1,20]]}}}